Clinical Trials
3 trialsNCT00458913 2018-07-12
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00513877 2014-12-31
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Cancer Trials Ireland
Phase 2 Completed
NCT00516100 2010-01-15
Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC
Aptium Oncology Research Network
Phase 1/2 Unknown